« Return to News | Awards & Advancement

Bayer elects Werner Wenning as chairman

Monday, September 17, 2012 03:08 PM

Bayer’s  supervisory board has elected Werner Wenning as its chairman, who had already been elected by the Annual Stockholders' Meeting of Bayer in April 27, 2012, to become a member of the supervisory board effective October 1.

Wenning served as chairman of the board of management of Bayer from April 2002 until September 2010. The statutory “cooling-off period,” after which a former member of a company’s board of management may join its supervisory board, ends after two years.

Wenning's career with Bayer spanned nearly 45 years, during which he rose from trainee to CEO. Wenning joined the company in 1966 as a commercial trainee, and subsequently held a number of positions with Bayer in Germany and abroad before being appointed to the board of management as CFO in February 1997. Five years later—in April 2002—he became chairman of the board of management of the pharmaceuticals and chemicals group.

Milestones during Wenning’s tenure as CEO included the strategic realignment of the Bayer Group and the spin-off of the traditional chemicals business under the name Lanxess. The most important and strategically decisive step toward expanding the life science business was the acquisition of Schering, of Berlin, Germany, in 2006.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.